Mary Kay Highlights the Importance of Women’s Leadership and Private Sector Engagement in Conservation at the World Ocean Summit 2023 Hosted by Economist Impact
22.3.2023 19:02:00 EET | Business Wire | Press release
Mary Kay Inc., a global advocate for corporate sustainability and signatory to the UN Global Compact Sustainable Ocean Principles, continues to play an important role in ocean conservation. In February, the beauty brand launched a groundbreaking, user-friendly platform offering valuable guidance, decision-support tools, and practical knowledge for marine practitioners. Following the announcement, Mary Kay recently participated at the 10th World Ocean Summit and Expo 2023 in Lisbon, Portugal, organized by Economist Impact.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230322005544/en/
Sandra Silva, Mary Kay Portugal’s General Manager participates on a panel on the topic of "Putting Coral Reef Restoration at the Heart of Ocean Conservation Action" at the World Ocean Summit in Lisbon, Portugal (Credit: Mary Kay Inc.).
The World Ocean Summit is an annual global event that brings together the widest cross-section of the ocean community, from business and finance to governments, national and international policymakers, civil society, and academia. Over 1,500 attendees from more than 100 countries attended the three-day summit, where 188 speakers addressed some of the most pressing challenges facing the ocean, such as climate change, biodiversity loss, and pollution.
Mary Kay Portugal's General Manager, Sandra Silva, was one of the distinguished panelists at the summit's "Putting Coral Reef Restoration at the Heart of Ocean Conservation Action" discussion, where she joined other notable speakers including Yabanex Batista from the Global Fund for Coral Reefs (United Nations), Tom Moore from King Abdullah University of Science and Technology (Saudi Arabia), and Deborah Brosnan from Deborah Brosnan & Associates.
Silva emphasized the importance of ocean conservation, stating, "The ocean is critical for the livelihoods of billions of people, and we all have a role to play in ocean conservation and a sustainable ocean economy. Mary Kay supports women's empowerment in all facets of life and business, including the health of our planet."
Martin Koehring, head of Economist Impact's World Ocean Initiative, stated, "Keeping momentum on ocean action, including through our summit and publications, is vital. This year, the summit drove progress by featuring cross-industry sessions to leverage synergies and encourage cross-sector engagement. Mary Kay's participation in the World Ocean Summit and Expo 2023 demonstrates its continued commitment to ocean conservation and its dedication to creating a sustainable future for all.”
The World Ocean Initiative transforms the momentum and focal point of the World Ocean Summit into a year-round program on the ocean that powers the full capabilities of Economist Impact, combining the ingenuity of a think-tank with the creativity of a media brand to engage a globally influential audience. The World Ocean Initiative seeks to enlighten, motivate and cultivate better collaboration between businesses, policymakers, investors, scientists, and NGOs to seek solutions to the most pressing ocean challenges and opportunities.
Mary Kay has been working to elevate ocean health and coral reef awareness through its partnership with The Nature Conservancy for over 32 years. One of the key projects Mary Kay supports is called "Super Reefs," which identifies, protects, and grows a global network of highly resilient coral reefs that can survive in a warming ocean.
“The Super Reefs team brings together reef governments and communities with experts in ocean science, conservation, and management from Woods Hole Oceanographic Institution, Stanford University, and The Nature Conservancy, along with private sector support from Mary Kay at this critical moment in the history of coral reefs,” said Dr. Elizabeth McLeod with The Nature Conservancy.
Click here to watch Putting Coral Reef Restoration At The Heart Of Ocean Conservation Action panel discussion.
DID YOU KNOW?
- The CEO Water Mandate is a UN Global Compact initiative that mobilizes business leaders on water, sanitation, and the United Nations Sustainable Development Goals. (Mary Kay is a signatory and joined in February 2021).
- The Sustainable Ocean Principles, produced in consultation with over 300 stakeholders, provide a framework for responsible business practices across sectors and geographies. They build upon and supplement the Ten Principles of the United Nations Global Compact on human rights, labor, environment, and anti-corruption. (Mary Kay is a signatory and joined in February 2021).
- The ocean has a key role to play in transitioning to a net-zero, resilient, and equitable economy, and delivering on the entire 2030 Agenda for Sustainable Development. The global business community has a shared responsibility, to take necessary action to secure a healthy ocean. (Mary Kay is a member and joined in August 2022).
ABOUT MARY KAY
One of the original glass ceiling breakers, Mary Kay Ash founded her dream beauty company in 1963 with one goal: enriching women’s lives. That dream has blossomed into a multibillion-dollar company with millions of independent sales force members in more than 35 countries. As an entrepreneurship development company, Mary Kay is committed to empowering women on their journey through education, mentorship, advocacy, networking, and innovation. Mary Kay is dedicated to investing in the science behind beauty and manufacturing cutting-edge skincare, color cosmetics, nutritional supplements, and fragrances. Mary Kay believes in enriching lives today for a sustainable tomorrow, partnering with organizations from around the world focusing on promoting business excellence, supporting cancer research, advancing gender equality, protecting survivors of domestic abuse, beautifying our communities, and encouraging children to follow their dreams. Learn more at marykayglobal.com, find us on Facebook, Instagram, and LinkedIn, or follow us on Twitter.
About The Nature Conservancy
The Nature Conservancy is a global conservation organization dedicated to conserving the lands and waters on which all life depends. Guided by science, we create innovative, on-the-ground solutions to our world’s toughest challenges so that nature and people can thrive together. We are tackling climate change, conserving lands, waters, and oceans at an unprecedented scale, providing food and water sustainably, and helping make cities more sustainable. Working in 76 countries and territories —37 by direct conservation impact and 39 through partners— we use a collaborative approach that engages local communities, governments, the private sector, and other partners. To learn more, visit www.nature.org or follow @nature_press on Twitter.
About the World Ocean Initiative
Economist Impact's World Ocean Initiative supports the development of a sustainable ocean economy by addressing the greatest challenges facing our seas: climate change, biodiversity loss, and pollution. Year-round and at our flagship World Ocean Summit, we inspire bold thinking, enable new partnerships, and explore the most effective action for a healthy blue planet. Find out more at impact.economist.com/ocean.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230322005544/en/
Contact information
Mary Kay Inc. Corporate Communications
marykay.com/newsroom
972.687.5332 or media@mkcorp.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 11:15:00 EEST | Press release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 20:42:00 EEST | Press release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 17:19:00 EEST | Press release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 17:15:00 EEST | Press release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 16:00:00 EEST | Press release
inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
